在Ipilimumab和Nivolumab联合免疫治疗后的支气管炎,在黑色素瘤患者中
Shahir Basir1, Jana Bosiers1, Hans M Westgeest2
1Department of Respiratory Medicine, Antwerp University Hospital, Edegem, Belgium.
免疫检查点抑制剂 (ICI) 在黑色素瘤患者中可能导致罕见的肺部问题,如支气管炎. 早期诊断和用类固醇停止ICI有效治疗了这种副作用.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了转移性黑色素瘤的治疗方法.
- 然而,ICI可以引起与免疫相关的不良事件 (AE),包括肺毒性.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
相关概念视频
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
COPD: Management Using Bronchodilators and Corticosteroids
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
